Professor Wender (PhD Yale University; NIH postdoctoral Fellow Columbia University) served on the faculty at Harvard University before joining the faculty at Stanford University where he is the Bergstrom
Professor of Chemistry and a Courtesy Professor in Chemical and Systems Biology. He is a member of the National Academy of Sciences, an advisor to the Stanford Molecular Imaging Program, a Sarafan ChEM-H Fellow, and affiliated with the Bio-X Program, the Center for Molecular Analysis and Design, the Stanford Cancer Institute, the Cancer Nanotechnology Program, and the Molecular Pharmacology Training Program. He is a cofounder of several biotech companies and serves/served on several science advisory boards, visiting committees and as a consultant to process and medicinal chemistry groups in the pharmaceutical and biotech industries. His research is directed at unsolved problems in chemistry, synthesis, biology, materials science, drug delivery, and medicine and includes approaches to HIV eradication, enhanced tumor
targeted therapy, Alzheimer’s disease, resistant cancer, resistant infections, and prophylactic and
therapeutic vaccinations.
Professor Wender (PhD Yale University; NIH postdoctoral Fellow Columbia University) served on the faculty at Harvard University before joining the faculty at Stanford University where he is the Bergstrom
Professor of Chemistry and a Courtesy Professor in Chemical and Systems Biology. He is a member of the National Academy of Sciences, an advisor to the Stanford Molecular Imaging Program, a Sarafan ChEM-H Fellow, and affiliated with the Bio-X Program, the Center for Molecular Analysis and Design, the Stanford Cancer Institute, the Cancer Nanotechnology Program, and the Molecular Pharmacology Training Program. He is a cofounder of several biotech companies and serves/served on several science advisory boards, visiting committees and as a consultant to process and medicinal chemistry groups in the pharmaceutical and biotech industries. His research is directed at unsolved problems in chemistry, synthesis, biology, materials science, drug delivery, and medicine and includes approaches to HIV eradication, enhanced tumor
targeted therapy, Alzheimer’s disease, resistant cancer, resistant infections, and prophylactic and
therapeutic vaccinations.
Professor Wender (PhD Yale University; NIH postdoctoral Fellow Columbia University) served on the faculty at Harvard University before joining the faculty at Stanford University where he is the Bergstrom
Professor of Chemistry and a Courtesy Professor in Chemical and Systems Biology. He is a member of the National Academy of Sciences, an advisor to the Stanford Molecular Imaging Program, a Sarafan ChEM-H Fellow, and affiliated with the Bio-X Program, the Center for Molecular Analysis and Design, the Stanford Cancer Institute, the Cancer Nanotechnology Program, and the Molecular Pharmacology Training Program. He is a cofounder of several biotech companies and serves/served on several science advisory boards, visiting committees and as a consultant to process and medicinal chemistry groups in the pharmaceutical and biotech industries. His research is directed at unsolved problems in chemistry, synthesis, biology, materials science, drug delivery, and medicine and includes approaches to HIV eradication, enhanced tumor
targeted therapy, Alzheimer’s disease, resistant cancer, resistant infections, and prophylactic and
therapeutic vaccinations.